{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:46:30Z","timestamp":1758991590664},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s10434-001-0449-y","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T02:20:04Z","timestamp":1109384404000},"page":"449-457","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Sodium Thiosulfate on Cisplatin Removal With Complete Hepatic Venous Isolation and Extracorporeal Charcoal Hemoperfusion: A Pharmacokinetic Evaluation"],"prefix":"10.1007","volume":"8","author":[{"given":"Nobuya","family":"Kusunoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonson","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanshiro","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/1097-0142(19800315)45:6<1278::AID-CNCR2820450603>3.0.CO;2-I","volume":"45","author":"DB Calvo","year":"1980","unstructured":"Calvo DB, Patt YZ, Wallace S, et al. Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy. Cancer 1980; 45: 1278?83.","journal-title":"Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1200\/JCO.1983.1.12.755","volume":"1","author":"TN Campbell","year":"1983","unstructured":"Campbell TN, Howell SB, Pfeifle CE, Wung WE, Bookstein J. Clinical pharmacokinetics of intraarterial cisplatin in humans. J Clin Oncol 1983; 1: 755?62.","journal-title":"J Clin Oncol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.2910600507","volume":"60","author":"AM Vexler","year":"1995","unstructured":"Vexler AM, Mou X, Gabizon AA, Gorodetsky R. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer 1995; 60: 611?5.","journal-title":"Int J Cancer"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/1097-0142(19910901)68:5<988::AID-CNCR2820680513>3.0.CO;2-8","volume":"68","author":"D Civalleri","year":"1991","unstructured":"Civalleri D, Esposito M, Fulco RA, et al. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer 1991; 68: 988?94.","journal-title":"Cancer"},{"key":"CR5","first-page":"41","volume":"90","author":"Y Ku","year":"1993","unstructured":"KuY, Samizo M, Fukumoto T, et al. Comparison of hepatic tissue extraction rates of cytotoxic anticancer drugs during hepatic arterial chemotherapy: evaluation using direct hemoperfusion under hepatic venous isolation [in Japanese with English abstract]. Jpn J Gastroenterol 1993; 90: 41?8.","journal-title":"Jpn J Gastroenterol"},{"key":"CR6","first-page":"273","volume":"107","author":"Y Ku","year":"1990","unstructured":"KuY, Saitoh M, Nishiyama H, et al. Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with veno-venous bypass. Surgery 1990; 107: 273?81.","journal-title":"Surgery"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF00309001","volume":"23","author":"Y Maekawa","year":"1993","unstructured":"Maekawa Y, KuY, Saitoh Y. Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: an experimental study on pharmacokinetics. Surgery Today Jpn J Surg 1993; 23: 58?62.","journal-title":"Surgery Today Jpn J Surg"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0039-6060(05)80250-8","volume":"117","author":"Y Ku","year":"1995","unstructured":"KuY, Fukumoto T, Iwasaki T, et al. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery 1995; 117: 510?9.","journal-title":"Surgery"},{"key":"CR9","first-page":"3339","volume":"58","author":"T Iwasaki","year":"1998","unstructured":"Iwasaki T, KuY, Kusunoki N, et al. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion. Cancer Res 1998; 58: 3339?43.","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9610(96)00422-9","volume":"173","author":"Y Ku","year":"1997","unstructured":"KuY, Fukumoto T, Tominaga M, et al. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. Am J Surg 1997; 173: 103?9.","journal-title":"Am J Surg"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00000658-199804000-00012","volume":"227","author":"Y Ku","year":"1998","unstructured":"KuY, Iwasaki T, Fukumoto T, et al. Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. Ann Surg 1998; 227: 519?26.","journal-title":"Ann Surg"},{"key":"CR12","first-page":"869","volume":"39","author":"Y Ku","year":"1999","unstructured":"KuY, Tominaga M, Iwasaki T, et al. Recent results of high-dose chemotherapy for advanced liver cancers with percutaneous isolated hepatic perfusion [in Japanese]. Kan Tan Sui 1999; 39: 869?76.","journal-title":"Kan Tan Sui"},{"key":"CR13","first-page":"202","volume":"8","author":"G Ehninger","year":"1985","unstructured":"Ehninger G, Ruckle H, Haag C, Wilms K. Die Therapie der Peritonealkarzinose mit Intraperitonealer Gabe von cis-Diaminodichloroplatin und systemischer Natrium Thiosulfat Protektion. Onkologie 1985; 8: 202?6.","journal-title":"Onkologie"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/clinchem\/32.4.641","volume":"32","author":"F Elferink","year":"1986","unstructured":"Elferink F, Vijgh WJF, Klein I, Pinedo HM. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin Chem 1986; 32: 641?5.","journal-title":"Clin Chem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/jnci\/81.20.1552","volume":"81","author":"R Goel","year":"1989","unstructured":"Goel R, Cleary SM, Horton C, et al. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst 1989; 81: 1552?60.","journal-title":"J Natl Cancer Inst"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00000542-198301000-00003","volume":"58","author":"AD Ivankovich","year":"1983","unstructured":"Ivankovich AD, Braverman B, Stephens TS, et al. Sodium thiosulfate disposition in humans: Relation to sodium nitroprusside toxicity. Anesthesiology 1983; 58: 11?17.","journal-title":"Anesthesiology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-2944(77)90089-8","volume":"18","author":"AF Leroy","year":"1977","unstructured":"Leroy AF, Wehling ML, Sponseller HL, et al. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 1977; 18: 184?91.","journal-title":"Biochem Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF00686189","volume":"36","author":"N Nagai","year":"1995","unstructured":"Nagai N, Hotta K, Yamamura H, Ogata H. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity. Cancer Chemother Pharmacol 1995; 36: 404?10.","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0378-4347(00)83855-4","volume":"529","author":"M Kinoshita","year":"1990","unstructured":"Kinoshita M, Yoshimura M, Ogata H, et al. High-performance liquid chromatographic analysis of unchanged cis-diamminedichloroplatinum (cisplatin) in plasma and urine with post-column derivatization. J Chromatogr 1990; 529: 462?7.","journal-title":"J Chromatogr"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00001813-199104000-00008","volume":"2","author":"SA Curley","year":"1991","unstructured":"Curley SA, Byrd DR, Newman RA, et al. Reduction of systemic drug exposure after Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system. Anti-Cancer Drugs 1991; 2: 175?83.","journal-title":"Anti-Cancer Drugs"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1200\/JCO.1994.12.12.2723","volume":"12","author":"TS Ravikumar","year":"1994","unstructured":"Ravikumar TS, Pizzorno G, Bodden W, et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol 1994; 12: 2723?36.","journal-title":"J Clin Oncol"},{"key":"CR22","first-page":"1426","volume":"43","author":"SB Howell","year":"1983","unstructured":"Howell SB, Pfeifle CE, Wung WE, Olshen RA. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 1983; 43: 1426?31.","journal-title":"Cancer Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/0277-5379(88)90061-2","volume":"24","author":"R Abe","year":"1988","unstructured":"Abe R, Akiyoshi T, Koba F, Tsuji H, Baba T. ?Two-route chemotherapy? using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies. Eur J Cancer Clin Oncol 1988; 24: 1671?4.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01613139","volume":"117","author":"M Markman","year":"1991","unstructured":"Markman M, D?Acquisto R, Iannotti N, et al. Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. J Cancer Res Clin Oncol 1991; 117: 151?5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(91)90064-C","volume":"43","author":"B Reichman","year":"1991","unstructured":"Reichman B, Markman M, Hakes T, et al. Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy. Gynecol Oncol 1991; 43: 159?63.","journal-title":"Gynecol Oncol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-97-6-845","volume":"97","author":"SB Howell","year":"1982","unstructured":"Howell SB, Pfeifle CL, Wung WE. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845?51.","journal-title":"Ann Intern Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/gyno.1993.1101","volume":"49","author":"H Malmstrom","year":"1993","unstructured":"Malmstrom H, Rasmussen S, Simonsen E. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer. Gynecol Oncol 1993; 49: 166?71.","journal-title":"Gynecol Oncol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0959-8049(05)80017-6","volume":"30A","author":"JP Guastalla","year":"1994","unstructured":"Guastalla JP, Vermorken JB, Wils JA, et al. Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy- a phase II study of the EORTC gynaecological cancer cooperative group. Eur J Cancer 1994; 30A: 45?9.","journal-title":"Eur J Cancer"},{"key":"CR29","first-page":"2356","volume":"11","author":"S Hayata","year":"1984","unstructured":"Hayata S, Hitoshi T, Kiyokawa K, Esaki S, Mihashi S, Hirano M. Pharmacokinetics of cisplatin and the effect of sodium thiosulfate [in Japanese with English abstract]. Jpn J Cancer Chemother 1984; 11: 2356?61.","journal-title":"Jpn J Cancer Chemother"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00263891","volume":"15","author":"Y Iwamoto","year":"1985","unstructured":"Iwamoto Y, Kawano T, Ishizawa M, Aoki K, Kuroiwa T, Baba T. Inactivation of cis-diamminedichloroplatinum (II) in blood and protection of its toxicity by sodium thiosulfate in rabbits. Cancer Chemother Pharmacol 1985; 15: 228?32.","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR31","first-page":"77","volume":"286","author":"EA Neuwelt","year":"1998","unstructured":"Neuwelt EA, Brummett RE, Doolittle ND, et al. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 1998; 286: 77?84.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR32","first-page":"98","volume":"18","author":"R Abe","year":"1986","unstructured":"Abe R, Akiyoshi T, Tsuji H, Baba J. Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate. Cancer Chemother Pharmacol 1986; 18: 98?100.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-001-0449-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0449-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:15:02Z","timestamp":1586132102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-001-0449-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1007\/s10434-001-0449-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}